Latest Articles

Publication Date
"Took me almost 2 decades": Prevention methods of disease that Njambi battled - Tuko.co.ke

"Took me almost 2 decades": Prevention methods of disease that Njambi battled Tuko.co.ke

Published: June 4, 2024, 7 a.m.
Endometriosis: A look at the painful disease that killed media personality Njambi Koikai - Bizna Kenya

Endometriosis: A look at the painful disease that killed media personality Njambi Koikai Bizna Kenya

Published: June 4, 2024, 7 a.m.
Endometriosis activists rally at Quidi Vidi Lake to reach others who suffer from disease - CBC.ca

Endometriosis activists rally at Quidi Vidi Lake to reach others who suffer from disease CBC.ca

Published: June 3, 2024, 7 a.m.
Construction and validation of a clinical risk model based on machine learning for screening characteristic factors of lymphovascular space invasion in endometrial cancer - Nature.com

Construction and validation of a clinical risk model based on machine learning for screening characteristic factors of lymphovascular space invasion in endometrial cancer Nature.com

Published: June 1, 2024, 7 a.m.
Personalized therapy in endometriosis — based on ERα or ERβ expression - BMC Medicine

Personalized therapy in endometriosis — based on ERα or ERβ expression BMC Medicine

Published: May 30, 2024, 7 a.m.
The mysterious case of endometriosis - New Era

The mysterious case of endometriosis New Era

Published: May 30, 2024, 7 a.m.
One Chicago woman’s health journey: six lung collapses, then a rare disease diagnosis - WBEZ Chicago

One Chicago woman’s health journey: six lung collapses, then a rare disease diagnosis WBEZ Chicago

Published: May 28, 2024, 7 a.m.
Estrogen-Only Therapy for Menopausal Symptoms Increases Ovarian Cancer Risk - Medpage Today

Estrogen-Only Therapy for Menopausal Symptoms Increases Ovarian Cancer Risk Medpage Today

Published: May 24, 2024, 7 a.m.
Brandi Rhodes Undergoes Surgery For Serious Disease - TheSportster

Brandi Rhodes Undergoes Surgery For Serious Disease TheSportster

Published: May 22, 2024, 7 a.m.
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer - GlobeNewswire

eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous …

Published: May 20, 2024, 7 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!